1. Market Research
  2. > Healthcare
  3. > Pathology Market Trends
  4. > 2015 New Frontiers in Point-of-Care/POC Infectious Disease Testing:Business Challenges, Emerging Technologies, Competitive Landscape

“2015 New Frontiers in Point-of-Care/POC Infectious Disease Testing: Business Challenges, Emerging Technologies, Competitive Landscape” is VPGMarketResearch’s new report, which provides comprehensive analysis of the  POC infections disease testing market, including its dynamics, size, growth, regulatory requirements, technological trends, competitive landscape, and emerging opportunities for instrument and consumable suppliers.


Rationale


The growing economic pressures on hospitals, coupled with advances in diagnostic technologies, intensifying competition among suppliers and physicians, and changing consumer demands are shifting diagnostic testing from hospitals and commercial laboratories closer to the patient.


Market Segmentation


- Review of the POC market segments, including their dynamics, trends, structure, size, growth and major suppliers.


- Five-year test volume and reagent sales forecasts for major infectious disease tests by market segment:



- Physician Offices/Group Practices    

- Emergency Rooms       

- Ambulatory Care Centers        

- Surgery Centers 

- Birth Centers


Sales and Market Share Analysis


- Sales and market shares of major reagent and instrument suppliers.


Infectious Disease Tests


AIDS/HIV, Adenovirus, Aeromonads, Bartonella, Blastocystis Hominis, Campylobacter, Candida, Chancroid, Chlamydia, Clostridium, Coronavirus, Coxsackievirus, Cryptosporidium, Cyclospora, CMV, E. Coli, Echovirus,  Encephalitis, Enterovirus, EBV, Giardia, Gonorrhea, Granuloma Inguinale, Hantavirus, H. Pylori, Hepatitis (A, B, C, D, E), Herpes Simplex Virus, Human Herpes Virus-6 (HHV-6), Influenza, Legionella, Lyme disease, Pymphogranuloma, Malaria, Measles, Meningitis, Mononucleosis, Microsporidium, Mononucleosis, Mumps, Mycoplasma, Polyomaviruses, Parvovirus B19, Pneumonia, Polyomaviruses, Pseudomonas, Rabies, RSV, Rhinovirus, Rheumatoid Arthritis, Rotavirus , Rubella, Salmonellosis, Septicemia, Shigella, Staphylococci, Streptococci, Syphilis, Toxoplasmosis, Trichomonas, Tuberculois, Vibrio, West Nile, Yersenia.


Technology Review


- Emerging technologies and their applications for POC testing.


- Comprehensive listings of companies developing or marketing POC diagnostic technologies

  and products, by test.


Strategic Recommendations


- Specific opportunities for new POC instruments and reagent systems with potentially

  significant market appeal during the next five years.


- Design criteria for POC testing products.


- Alternative business expansion strategies.


- Potential market entry barriers and risks.


Competitive Assessments


- Assessments of major suppliers and emerging market entrants, including their sales, product

  portfolios, marketing tactics, joint ventures, and new products in R&D.


- The companies analyzed in the report include:


   - Abbott

   - Affymetrix

   - Beckman Coulter/Danaher

   - Becton Dickinson

   - Biomerieux

   - Bio-Rad

   - Cepheid       

   - Diamedix           

   - Diasorin

   - Eiken Chemical

   - Elitech Group

   - Enzo Biochem

   - Fujirebio

   - Grifols

   - Hologic/Gen-Probe

   - ID Biomedical/GSK

   - Kreatech/Leica

   - Lonza

   - Ortho-Clinical Diagnostics

   - Qiagen

   - Roche

   - Scienion

   - Sequenom

   - SeraCare

   - Siemens

   - Takara Bio

   - ThermoFisher

   - Wallac/PE

   - Wako

  

Methodology


This report is based on a combination of primary and secondary sources of information, including review of recent technical and business publications, manufacturer product literature, industry analyst reports, and Venture Planning Group's proprietary data files.


Contains 835 pages and 80 tables

“2015 New Frontiers in Point-of-Care/POC Infectious Disease Testing: Business Challenges, Emerging Technologies, Competitive Landscape” is VPGMarketResearch’s new report, which provides comprehensive analysis of the POC infections disease testing market, including its dynamics, size, growth, regulatory requirements, technological trends, competitive landscape, and emerging opportunities for instrument and consumable suppliers.

Table Of Contents

2015 New Frontiers in Point-of-Care/POC Infectious Disease Testing:Business Challenges, Emerging Technologies, Competitive Landscape
Table of Contents

I. Introduction
II. Worldwide Market Overview
A. Business Environment
B. Market Structure
C. Market Size and Growth
III. Major Product Development Opportunities
A. Instrumentation
B. Reagent Kits and Test Systems/Panels
C. Information Technology
D. Auxiliary Products
IV. Design Criteria for Decentralized Testing Products
V. Alternative Market Penetration Strategies
A. Internal Development
B. Collaborative Arrangements
C. University Contracts
D. Distribution Strategies for Decentralized
Testing Markets
VI. Potential Market Entry Barriers and Risks
A. Market Maturity
B. Cost Containment
C. Competition
D. Technological Edge and Limitations
E. Patent Protection
F. Regulatory Constraints
G. Decentralized Testing Market Challenges

VII. Worldwide Overview of Major Tests,
Technologies, and Instrumentation
A. Major Infectious Disease Tests
1. AIDS: HIV/HIV-1/2/Combo, HIVAg/HIV NAT,
Western Blot, HTLV-I/II
2. Adenovirus
3. Aeromonas
4. Anthrax/Bacillus Anthracis
5. Arboviruses
6. Babesiosis
7. Bacillary Epithelioid Angiomatosis (BEA)
and Other Bartonella (Rochalimaea)
8. Blastocystis Hominis
9. Brucella
10. Campylobacter
11. Candida
12. Chagas Disease
13. Chancroid
14. Chlamydia
15. Clostridium Difficile
16. Coronaviruses
17. Coxsackieviruses
18. Creutzfeldt-Jakob's Disease
19. Cryptosporidium Parvum
20. Cyclospora Cayetanensis
21. Cytomegalovirus
22. Ebola Virus
23. E. Coli
24. EchoVirus
25. Encephalitis
26. Enteroviruses
27. Epstein-Barr Virus
28. Giardia Lamblia
29. Gonorrhea
30. Granuloma Inguinale
31. Hantavirus
32. Helicobacter Pylori

33. Hepatitis: HAV NAT, HBV NAT, HBs Ag, HCV, HCV NAT,
Anti-HBc, Anti-HBs, Anti-HAV, Hepatitis Delta, HBc Ag,
HBe Ag, ALT/SGPT
34. Herpes Simplex Virus
35. Human Herpes Virus-6 (HHV-6)
36. Influenza Viruses
37. Legionella
38. Lyme Disease
39. Lymphogranuloma Venereum (LGV)
40. Malaria
41. Measles (Rubeola)
42. Meningitis
43. Microsporidium
44. Mononucleosis
45. Mumps
46. Mycoplasma
47. Papillomaviruses
48. Parvovirus B19
49. Pneumonia
50. Polyomaviruses
51. Pseudomonas Aeruginosa
52. Rabies
53. Respiratory Syncytial Virus (RSV)
54. Rhinoviruses
55. Rotavirus
56. Rubella
57. Salmonellosis
58. Septicemia
59. Shigellosis
60. Staphylococcus Aureus
61. Streptococci
62. Syphilis
63. Toxoplasmosis
64. Trichomonas Vaginalis
65. Tuberculosis
66. Vibrio
67. West Nile Virus
68. Yersina


B. Instrumentation Review: Operating Characteristics,
Features and Selling Princes of Leading Infectious Disease
Automated and Semiautomated Analyzers
C. Emerging Infectious Disease Diagnostic Technologies
1. Molecular Diagnostics
2. Monoclonal Antibodies
3. Immunoassays
4. Differential Light Scattering
5. Information Technology
6. Artificial Intelligence
7. Liposomes
8. Flow Cytometry
9. Chromatography
10. Diagnostic Imaging
11. Gel Microdroplets
12. Others
D. Personal Testing
VIII. France Infectious Disease Testing Market
A. Executive Summary
B. Business Environment
C. Market Structure
D. Market Size, Volume by Method, Test Volume
and Sales Forecasts by Market Segment,
Major Supplier Sales and Market Shares by Test
IX. Germany Infectious Disease Testing Market
A. Executive Summary
B. Business Environment
C. Market Structure
D. Market Size, Volume by Method, Test Volume
and Sales Forecasts by Market Segment,
Major Supplier Sales and Market Shares by Test

X. Italy Infectious Disease Testing Market
A. Executive Summary
B. Business Environment
C. Market Structure
D. Market Size, Volume by Method, Test Volume
and Sales Forecasts by Market Segment,
Major Supplier Sales and Market Shares by Test
XI. Japan Infectious Disease Testing Market
A. Executive Summary
B. Business Environment
C. Market Structure
D. Market Size, Volume by Method, Test Volume
and Sales Forecasts by Market Segment,
Major Supplier Sales and Market Shares by Test
XII. Spain Infectious Disease Testing Market
A. Executive Summary
B. Business Environment
C. Market Structure
D. Market Size, Volume by Method, Test Volume
and Sales Forecasts by Market Segment,
Major Supplier Sales and Market Shares by Test
XIII. U.K. Infectious Disease Testing Market
A. Executive Summary
B. Business Environment
C. Market Structure
D. Market Size, Volume by Method, Test Volume
and Sales Forecasts by Market Segment,
Major Supplier Sales and Market Shares by Test
XIV. U.S.A. Infectious Disease Testing Market
A. Executive Summary
B. Business Environment
C. Market Structure
D. Market Size, Volume by Method, Test Volume
and Sales Forecasts by Market Segment,
Major Supplier Sales and Market Shares by Test

XV. Competitive Assessments
- Abbott
- Affymetrix
- Beckman Coulter/Danaher
- Becton Dickinson
- bioMerieux
- Bio-Rad
- Cepheid
- Diamedix
- DiaSorin
- Eiken Chemical
- Elitech Group
- Enzo Biochem
- Fujirebio
- Grifols
- Hologic/Gen-Probe
- ID Biomedical/GSK
- Kreatech/Leica
- Lonza
- Ortho-Clinical Diagnostics
- Qiagen
- Roche
- Scienion
- Sequenom
- SeraCare
- Siemens
- Takara Bio
- Thermo Fisher
- Wallac/PE
- Wako

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
2017 World Infectious Disease Testing Market: North America, Europe, Asia-Pacific, LATAM, Africa, Middle East--Sales and Volume Forecasts for 100 Microbiology Tests, Supplier Shares, Competitive Strategies, Instrumentation, Technologies, Opportunities

2017 World Infectious Disease Testing Market: North America, Europe, Asia-Pacific, LATAM, Africa, Middle East--Sales and Volume Forecasts for 100 Microbiology Tests, Supplier Shares, Competitive Strategies, Instrumentation, Technologies, Opportunities

  • $ 59500
  • Industry report
  • January 2017
  • by Venture Planning Group

This unique 68-country survey from VPGMarketResearch.com provides data and analysis not available from any other published source. The survey is designed to assist diagnostics industry executives, as well ...

2017 World Transfusion Diagnostics Market: North America, Europe, Asia-Pacific, LATAM, Middle East--Volume and Sales Forecasts for 40 Tests, Supplier Shares, Competitive Strategies, Instrumentation, Technologies

2017 World Transfusion Diagnostics Market: North America, Europe, Asia-Pacific, LATAM, Middle East--Volume and Sales Forecasts for 40 Tests, Supplier Shares, Competitive Strategies, Instrumentation, Technologies

  • $ 43500
  • Industry report
  • January 2017
  • by Venture Planning Group

This comprehensive 68-country report from VPGMarketResearch.com provides granular data and analysis not available from any other source. The report is designed to help current suppliers and potential market ...

2017 World Blood Typing, Grouping and Infectious Disease Screening Market: North America, Europe, Asia-Pacific, LATAM, Middle East--Volume and Sales Forecasts for 40 Tests, Supplier Shares, Competitive Strategies, Instrumentation, Technologies

2017 World Blood Typing, Grouping and Infectious Disease Screening Market: North America, Europe, Asia-Pacific, LATAM, Middle East--Volume and Sales Forecasts for 40 Tests, Supplier Shares, Competitive Strategies, Instrumentation, Technologies

  • $ 43500
  • Industry report
  • January 2017
  • by Venture Planning Group

This comprehensive 68-country report from VPGMarketResearch.com provides granular data and analysis not available from any other source. The report is designed to help current suppliers and potential market ...


ref:plp2015

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.